Heritage Pharmaceuticals Inc.

Heritage Introduces Propranolol Tablets

Published in Drug Week, October 31st, 2008

Heritage Pharmaceuticals Inc. announced the immediate availability of Propranolol HCl Oral Tablets in 10, 20, 40, 60 and 80 mg strength. Heritage's development and manufacturing partner, Ipca Laboratories Ltd., received final approval of its Abbreviated New Drug Application (ANDA) for an AB Rated equivalent of Inderal(R) on June 2, 2008.

Propranolol Tablets are the generic equivalent of Inderal(R) Tablets formerly marketed by Wyeth. Propranolol has multiple cardiovascular related indications, including the management of hypertension, treatment of angina and atrial fibrillation. Propranolol had U.S. brand and generic sales of approximately $25 million for the 12-month...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2008-10-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry